Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 496

1.

An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.

Scott KA, Moore RJ, Arnott CH, East N, Thompson RG, Scallon BJ, Shealy DJ, Balkwill FR.

Mol Cancer Ther. 2003 May;2(5):445-51.

2.

Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis.

Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G, Balkwill F.

Nat Med. 1999 Jul;5(7):828-31. Erratum in: Nat Med 1999 Sep;5(9):1087.

PMID:
10395330
3.

Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development.

Arnott CH, Scott KA, Moore RJ, Robinson SC, Thompson RG, Balkwill FR.

Oncogene. 2004 Mar 11;23(10):1902-10.

PMID:
14661063
4.

Discrete roles of cytokines, TNF-alpha, IL-1, IL-6 in tumor promotion and cell transformation.

Suganuma M, Okabe S, Kurusu M, Iida N, Ohshima S, Saeki Y, Kishimoto T, Fujiki H.

Int J Oncol. 2002 Jan;20(1):131-6.

PMID:
11743653
6.

Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline.

Robertson FM, Ross MS, Tober KL, Long BW, Oberyszyn TM.

Carcinogenesis. 1996 Aug;17(8):1719-28.

7.
9.

Essential role of tumor necrosis factor alpha (TNF-alpha) in tumor promotion as revealed by TNF-alpha-deficient mice.

Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E, Fujiki H.

Cancer Res. 1999 Sep 15;59(18):4516-8.

10.

Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway.

Arnott CH, Scott KA, Moore RJ, Hewer A, Phillips DH, Parker P, Balkwill FR, Owens DM.

Oncogene. 2002 Jul 18;21(31):4728-38.

12.

Tumor progression of murine epidermal cells after treatment in vitro with 12-O-tetradecanoylphorbol-13-acetate or retinoic acid.

Kulesz-Martin MF, Blumenson LE, Manly KF, Siracký J, East CJ.

Cancer Res. 1991 Sep 1;51(17):4701-6.

13.

Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion.

Robertson FM, Bijur GN, Oberyszyn AS, Pellegrini AE, Boros LG, Sabourin CL, Oberyszyn TM.

Carcinogenesis. 1994 May;15(5):1017-29.

PMID:
8200063
14.

Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.

Allen SM, Florell SR, Hanks AN, Alexander A, Diedrich MJ, Altieri DC, Grossman D.

Cancer Res. 2003 Feb 1;63(3):567-72.

15.

FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.

Hennings H, Glick AB, Lowry DT, Krsmanovic LS, Sly LM, Yuspa SH.

Carcinogenesis. 1993 Nov;14(11):2353-8.

PMID:
8242866
16.

Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin.

Hsieh YH, Juliana MM, Hicks PH, Feng G, Elmets C, Liaw L, Chang PL.

Cancer Res. 2006 Jul 15;66(14):7119-27.

17.
18.

Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis.

Li AG, Lu SL, Zhang MX, Deng C, Wang XJ.

Cancer Res. 2004 Nov 1;64(21):7836-45.

19.

Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice.

Zhou HM, Bolon I, Nichols A, Wohlwend A, Vassalli JD.

Cancer Res. 2001 Feb 1;61(3):970-6.

20.

Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide.

Mancuso M, Pazzaglia S, Tanori M, Rebessi S, Di Majo V, Covelli V, Saran A.

Mutat Res. 2004 Apr 14;548(1-2):35-45.

PMID:
15063134
Items per page

Supplemental Content

Support Center